STAT+: Kennedy’s closing arguments for the 2026 midterms: Fraud, vaccines, and MAHA

On Wednesday night in Clive, Iowa, MAHA activists and Republican candidates gathered to support Zach Lahn’s campaign for governor. Speakers attacked Big Agriculture, highlighted rising chronic disease, and called for the Covid-19 vaccine to be removed from the market. The event linked health policy with Lahn’s Republican campaign.

Florida Surgeon General Joseph Ladapo made inaccurate claims about the hepatitis B vaccine. Michael Boes, Steak ’n Shake’s chief MAHA officer, called the movement a catalyst for a “monumental shift.” Zen Honeycutt urged an end to liability shields for pesticide and pharmaceutical companies.

Kennedy appeared after Lahn and received the night’s main spotlight. He called Lahn’s platform a “spiritual battle” and argued that food should be grown without poisoning children, causing cancer, or damaging soil and the microbiome. The rally showed how MAHA themes are being folded into Republican campaigning, although the article gives no indication that the proposals have become law.

Make America Healthy Again, or MAHA, is a political movement that argues American health is being harmed by modern food and chemical systems. In the article, its central concerns include rising chronic disease, Big Agriculture, pesticide exposure, pharmaceutical liability, soil health, and the Covid-19 vaccine. The movement presents food and environmental policy as public-health issues.

The rally offered several examples. Kennedy called for growing food without poisoning children, giving people cancer, or destroying soils and their microbiome. Zen Honeycutt called for ending liability shields for pesticide and pharmaceutical companies. Other speakers connected the movement to opposition to the Covid-19 vaccine and criticism of vaccine-related claims.

MAHA’s influence is political as well as health-focused. Michael Boes called it a catalyst for a “monumental shift,” while Kennedy supported Iowa candidate Zach Lahn. The article shows MAHA themes entering a Republican campaign, but it does not define a formal membership structure or provide evidence for all of its health claims.

Robert F. Kennedy Jr. is the health secretary and the rally’s main attraction. He has been an ardent supporter of Zach Lahn, the farmer-turned-Republican candidate for Iowa governor. Kennedy followed Lahn onstage and presented Lahn’s health and agriculture platform as a major moral and political struggle.

Joseph Ladapo is Florida’s surgeon general. At the rally, he made inaccurate claims about the hepatitis B vaccine. Lahn is the candidate being supported. His campaign largely revolves around taking down Big Agriculture, which gives MAHA activists a way to connect national health arguments with Iowa politics.

Their roles create a shared campaign message. Lahn supplies the state-level candidacy, Kennedy supplies national prominence, and Ladapo supplies a prominent public-health voice. The article also identifies other speakers, including Michael Boes and Zen Honeycutt. It does not describe formal campaign titles for Kennedy or Ladapo beyond their stated public roles.

Chronic diseases are widespread in the United States. The CDC has reported that about six in ten adults have at least one chronic disease, while about four in ten have two or more. The exact figures vary by definition and year, and the source article itself gives no prevalence numbers. Conditions commonly counted include heart disease, cancer, diabetes, and chronic lung disease.

Their increase affects daily life and public budgets. Long-term illness can require continuing treatment, medicines, monitoring, and time away from work. That makes prevention a political question. Campaigns can argue over whether the main causes are personal behavior, food systems, environmental exposures, unequal access to care, or several factors together.

The Clive rally used chronic disease as a reason to challenge Big Agriculture and current health policy. Kennedy tied health to soil and food production, while Lahn’s platform focused on agriculture. The issue is likely to remain politically powerful because it links personal health with regulation, industry accountability, and government spending, though the article does not establish one cause for the increase.

If Covid-19 vaccines were removed from the U.S. market, patients could no longer obtain them through ordinary lawful commercial channels. People seeking vaccination would face fewer choices, and some could lose timely access to updated protection. The consequences would depend on whether the decision covered every product and whether other legal pathways remained.

Doctors would have fewer tools for preventing severe Covid-19, especially for patients at higher risk. They would need to discuss alternatives, eligibility, timing, and changing evidence with patients. Pharmacies, clinics, manufacturers, insurers, and public-health programs would also have to change their operations. Removing a product would not itself erase existing medical records or past vaccinations.

The article reports that rally speakers called for removal, but it does not say that removal occurred or that officials adopted the demand. In reality, vaccine access is governed by regulatory decisions and available evidence. Any market withdrawal would therefore be a major policy change, with effects depending on the specific products, legal authority, and replacement options.

Liability shields are laws or legal provisions that protect companies from some lawsuits, damages, or other consequences when their products allegedly cause harm. They do not necessarily provide complete immunity. The scope depends on the statute, the product, the alleged injury, and exceptions such as misconduct or failure to follow requirements.

For example, a liability shield for a pharmaceutical or pesticide company could block a claim, limit damages, or require a particular legal process. Ending or narrowing that protection could let more injured people sue and could expose companies to greater financial risk. It could also encourage stronger warnings, testing, or safety controls, though the actual effect depends on court decisions and the law.

At the Iowa rally, Zen Honeycutt called for ending liability shields for pesticide and pharmaceutical companies. The article does not identify a specific shield, lawsuit, or proposed bill. It therefore establishes the political demand, not its legal details or likely outcome. Any change would require lawmakers or courts with authority over the relevant protection.

Vaccine evaluation begins with laboratory research and, when appropriate, animal studies. Human trials then usually proceed in phases. Early studies examine safety and dosing. Larger studies look for immune responses and common side effects. Later trials compare vaccinated and unvaccinated groups or another control to measure protection and detect risks. The evidence is not perfect, so regulators weigh benefits against known and potential harms.

Regulatory reviewers examine trial data, manufacturing quality, proposed labeling, and the intended population. In the United States, the Food and Drug Administration decides whether a vaccine meets the legal standard for authorization or approval. The Centers for Disease Control and Prevention separately issues recommendations about use through its advisory process. Those decisions determine how vaccination is offered.

Monitoring continues after public release. Systems such as VAERS, clinical studies, electronic health-record analyses, and active surveillance can identify signals that trials may miss because rare events need very large populations. Regulators can investigate, update warnings, change recommendations, restrict use, or withdraw a product. The source article does not discuss these processes, so this explanation uses established U.S. vaccine practice.